Forma Therapeutics, Watertown, MA

Forma Therapeutics

www.formatherapeutics.com

At FORMA, patients are our purpose. We are dedicated to delivering transformative medicines to patients with cancer and rare diseases. We are a fully-integrated, privately-held clinical stage biopharmaceutical company. A leader in metabolism, epigenetics and protein homeostasis focused on the discovery, development and commercialization of transformative medicines. Our proprietary R&D platform combines deep biology insight, chemistry expertise and clinical development capabilities to create differentiated drug candidates. We have delivered high-value clinical candidates to our partners and generated a broad proprietary portfolio of internal programs, ranging from pre-clinical to pivotal-stage, with the potential to provide profound patient benefit in hematologic, oncologic ...

More>>

Number of Employees: 100-250
Annual Revenue: $10-50 Million

www.formatherapeutics.com
500 Arsenal Street Suite 100
Watertown, MA USA 02472
Phone: 617.679.1970

Name	Title	Contact Details
Kathryn Tabb	Director, Clinical Counsel	Profile
Jeannette Potts	Senior Vice President, General Counsel and Corporate Secretary	Profile
Christine Bellon	Senior Vice President, General Counsel and Corporate Secretary	Profile

Similar Companies

Telix Pharmaceuticals

Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical needs in oncology and rare diseases.

CLOs on the Move